Several years ago a new lung cancer drug was being evaluated, and when the authors looked  at whose tumors shrank, they found that 82 percent were women.
몇 년 전, 새로운 폐암 치료제를 평가하고 있었는데, 평가원들이 누구의  암 덩어리가 줄어들었는지 보자, 82%가 여성의 암덩어리었던 것으로 확인되었습니다.